Get Started

DRMA

NASD Dermata Therapeutics, Inc.
Oct 29, 2026 · 12:42 AM ET EOD Market Closed

$0.8747 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.8747, $0.0157 below the day’s high of $0.8904

YTD change
-62.30%
vs 20-day SMA
-5.92%
vs 200-day SMA
-34.45%

Price ranges

Previous day
$0.6727 $0.7697
open $0.7360 close $0.7550
+$0.0190 (+2.58%)
Today
$0.7501 $0.8904
open $0.7700 now $0.8747
+$0.1047 (+13.60%)
Past week
$0.6727 $0.8898
from $0.8699 now $0.8747
+$0.0048 (+0.55%)
Past month
$0.6032 $1.1800
from $1.1300 now $0.8747
-$0.2553 (-22.59%)
This year
$0.6032 $4.6600
from $2.3200 now $0.8747
-$1.4453 (-62.30%)

Price & Performance

-0.39 (-30.58%) / 6M

$0.5788$0.9874$1.40$1.80Apr 28Jul 29Oct 28

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Neutral
  • The stock is 99.9% away from all-time highs of $1,668.0000
  • DRMA is down 62% since the beginning of the year
  • DRMA is down 77% over the past 12 months
  • DRMA is down 23% over the past 1 month
  • 1% of all DRMA investors are betting against DRMA

DRMA reads neutral: price sits below both the 20- and 200-day averages, the 12-month move is -76.7%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.74
Earnings momentum -34.5% Quarterly EPS growth
Quarterly change -34.5%

Valuation

P/E ratio N/A
Enterprise value $-1376050.0
Beta 1.09

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$4.4M
DebtN/A
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $5.5M

Dermata Therapeutics, Inc. is a clinical-stage medical dermatology company that focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin diseases. The company was founded by David F. Hale and Gerald T. Proehl on December 8, 2014 and is headquartered in San Diego, CA.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $451.83 +0.87%
MRNA Moderna, Inc. $214.17 +2.98%
RVMD Revolution Medicines, Inc. $188.72 +1.34%
ROIV Roivant Sciences Ltd. $37.11 +1.56%
BNTX BioNTech SE Sponsored ADR $87.99 +1.07%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.